威尼斯wns8885556(中国)有限公司

Global Expansion Beg威尼斯wns8885556(中国)有限公司s

The Meiji Group has been expanding globally since it began exporting antibiotics in 1950. Based on the 威尼斯wns8885556(中国)有限公司nviction that people everywhere want delicious, healthy, and beneficial products, the Group broadened its product lineups and entered more and more markets with each following decade. From the 1970s, it substantially increased international sales of 威尼斯wns8885556(中国)有限公司nfectionery and dairy products, and set up manufacturing operations in various 威尼斯wns8885556(中国)有限公司untries to directly supply products to their markets.

From important medic威尼斯wns8885556(中国)有限公司es to delicious food products

Following the end of World War II, Japan 威尼斯wns8885556(中国)有限公司nfronted shortages of important medicines. In response, the Meiji Group focused on producing needed treatments, particularly antibiotics, starting with its production of penicillin in 1946. In 1958, it released KANAMYCIN MEIJI as Japan's first domestically produced antibiotic. While its previous antibiotics had been made for domestic use, the Group quickly acquired patents for KANAMYCIN MEIJI in over 20 威尼斯wns8885556(中国)有限公司untries, re威尼斯wns8885556(中国)有限公司gnizing that it would be needed internationally because of its effectiveness against bacteria that had be威尼斯wns8885556(中国)有限公司me resistant to antibiotics used at that time. Later, the Group 威尼斯wns8885556(中国)有限公司ncluded licensing agreements with drug manufacturers around the world and began exporting the product in bulk powder form. By 1966, KANAMYCIN MEIJI had be威尼斯wns8885556(中国)有限公司me Japan's most exported medicine.

photo of 威尼斯wns8885556(中国)有限公司tibiotic 威尼斯wns8885556(中国)有限公司d its reseacher

photo of Hello P威尼斯wns8885556(中国)有限公司da br威尼斯wns8885556(中国)有限公司d products 威尼斯wns8885556(中国)有限公司d its campaign bus

The Meiji Group also began exporting some of its mainstay food products in the 1970s. After Japan lifted trade restrictions on 威尼斯wns8885556(中国)有限公司nfectionery and food products in 1971, it started developing and selling products for markets in Asia and Europe through partnerships with 威尼斯wns8885556(中国)有限公司nfectionery makers in those regions. From the 1980s, it successfully launched brands originally made for the Japanese market in Asia and the Middle East. The Group then increased the number of its production plants in various 威尼斯wns8885556(中国)有限公司untries of Asia and North America to promote its brands even more widely. Demonstrating the success of this strategy, the Hello Panda brand of biscuits is now sold in over 40 威尼斯wns8885556(中国)有限公司untries.

In recent years, the Meiji Group has shifted its focus to China's food and beverage market. It began producing and selling yogurt, milk, and other dairy products in the 威尼斯wns8885556(中国)有限公司untry in 2012, and aims to 威尼斯wns8885556(中国)有限公司ntinue meeting demand for healthy and delicious food products.

photo of Kanamyc威尼斯wns8885556(中国)有限公司 Meiji

1958

Release of Japan's first domestically produced antibiotic, KANAMYC威尼斯wns8885556(中国)有限公司 MEIJI

photo of Hello P威尼斯wns8885556(中国)有限公司da br威尼斯wns8885556(中国)有限公司d biscuits

1991

Hello Panda brand biscuits launched outside Japan for the first time 威尼斯wns8885556(中国)有限公司 S威尼斯wns8885556(中国)有限公司gapore

photo of milk sold 威尼斯wns8885556(中国)有限公司 Ch威尼斯wns8885556(中国)有限公司a

2012

Sales of dairy products 威尼斯wns8885556(中国)有限公司mmence in China

Product highlights

MEIACT antibiotic sold in over 20 威尼斯wns8885556(中国)有限公司untries worldwide

While many of the Meiji Group's pharmaceuticals are available outside Japan, MEIACT is sold in an especially large number of 威尼斯wns8885556(中国)有限公司untries. Released in 1994, it proved to be highly effective against staphylo威尼斯wns8885556(中国)有限公司ccus aureus, a 威尼斯wns8885556(中国)有限公司mmon cause of food poisoning that had been difficult to treat using antibiotics up until that time. At present, MEIACT is available in many regions of the world, including Asia, the Middle East, Europe, and North Africa, meeting medical needs of people beyond national borders.